The Marvelous Journey of a Skilled Healer.

Summary

The conversation revolves around the urgent need for Sanwei Pharmaceutical to finalize the EU GMP standard testing for traditional Chinese medicine, which incurs substantial costs. Xia Yu expresses concern over the financial burden, as applying for each product costs around 10 million, totaling approximately 7.8 billion for a batch. Despite monthly profits, the company faces losses due to testing expenses, relying on Qi Huang Charity for funding. Su Tao emphasizes the importance of investing early to reap benefits and acknowledges market competition. He believes that as traditional Chinese medicine gains recognition, the market will expand, benefiting Sanwei. The dialogue also touches on the need for rapid product development and the strategic entry into the Russian market. Su Tao's management style focuses on motivating his team, ensuring they feel valued and capable.

Full content